A citation-based method for searching scientific literature

Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
Times Cited: 573







List of co-cited articles
696 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
538
26

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
368
25

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
21

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
18

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
16

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
15

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
11

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
914
11

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
11

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
367
11

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
940
11

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
402
11

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
10

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
923
10

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
10

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
522
10

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
159
10

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
379
9

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
416
8

Pirfenidone in idiopathic pulmonary fibrosis.
H Taniguchi, M Ebina, Y Kondoh, T Ogura, A Azuma, M Suga, Y Taguchi, H Takahashi, K Nakata, A Sato,[...]. Eur Respir J 2010
623
8


A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
643
7

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Peter M George, Athol U Wells, R Gisli Jenkins. Lancet Respir Med 2020
414
7

Lung transplantation for idiopathic pulmonary fibrosis.
Peter M George, Caroline M Patterson, Anna K Reed, Muhunthan Thillai. Lancet Respir Med 2019
69
10

Metformin reverses established lung fibrosis in a bleomycin model.
Sunad Rangarajan, Nathaniel B Bone, Anna A Zmijewska, Shaoning Jiang, Dae Won Park, Karen Bernard, Morgan L Locy, Saranya Ravi, Jessy Deshane, Roslyn B Mannon,[...]. Nat Med 2018
212
7

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
Paul A Reyfman, James M Walter, Nikita Joshi, Kishore R Anekalla, Alexandra C McQuattie-Pimentel, Stephen Chiu, Ramiro Fernandez, Mahzad Akbarpour, Ching-I Chen, Ziyou Ren,[...]. Am J Respir Crit Care Med 2019
400
7

Developmental pathways in the pathogenesis of lung fibrosis.
Diptiman Chanda, Eva Otoupalova, Samuel R Smith, Thomas Volckaert, Stijn P De Langhe, Victor J Thannickal. Mol Aspects Med 2019
104
7

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, Moritaka Suga, Shosaku Abe, Koichiro Nakata, Yoshio Taguchi, Sonoko Nagai, Harumi Itoh, Motoharu Ohi,[...]. Am J Respir Crit Care Med 2005
629
6

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.
Omkar Desai, Julia Winkler, Maksym Minasyan, Erica L Herzog. Front Med (Lausanne) 2018
106
6

Immune Mechanisms in Pulmonary Fibrosis.
Saeed Kolahian, Isis E Fernandez, Oliver Eickelberg, Dominik Hartl. Am J Respir Cell Mol Biol 2016
126
6

Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Lei Zhang, Yi Wang, Guorao Wu, Weining Xiong, Weikuan Gu, Cong-Yi Wang. Respir Res 2018
97
6

New insights into TGF-β/Smad signaling in tissue fibrosis.
He-He Hu, Dan-Qian Chen, Yan-Ni Wang, Ya-Long Feng, Gang Cao, Nosratola D Vaziri, Ying-Yong Zhao. Chem Biol Interact 2018
286
6


Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis.
Arun C Habermann, Austin J Gutierrez, Linh T Bui, Stephanie L Yahn, Nichelle I Winters, Carla L Calvi, Lance Peter, Mei-I Chung, Chase J Taylor, Christopher Jetter,[...]. Sci Adv 2020
152
6

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.
Taylor S Adams, Jonas C Schupp, Sergio Poli, Ehab A Ayaub, Nir Neumark, Farida Ahangari, Sarah G Chu, Benjamin A Raby, Giuseppe DeIuliis, Michael Januszyk,[...]. Sci Adv 2020
175
6


Inflammation and immunity in IPF pathogenesis and treatment.
P Heukels, C C Moor, J H von der Thüsen, M S Wijsenbeek, M Kool. Respir Med 2019
97
6

The therapy of idiopathic pulmonary fibrosis: what is next?
Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, Nicolas Kahn, Veronika Müller, Michael Kreuter. Eur Respir Rev 2019
67
8

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype.
Amy L Olson, Alex H Gifford, Naohiko Inase, Evans R Fernández Pérez, Takafumi Suda. Eur Respir Rev 2018
70
7

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
588
5

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
Yongyu Wang, Phillip J Kuan, Chao Xing, Jennifer T Cronkhite, Fernando Torres, Randall L Rosenblatt, J Michael DiMaio, Lisa N Kinch, Nick V Grishin, Christine Kim Garcia. Am J Hum Genet 2009
298
5

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.
Carlo Vancheri, Michael Kreuter, Luca Richeldi, Christopher J Ryerson, Dominique Valeyre, Jan C Grutters, Sabrina Wiebe, Wibke Stansen, Manuel Quaresma, Susanne Stowasser,[...]. Am J Respir Crit Care Med 2018
110
5

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Phillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, Patrick Mallia, Kirsty E Russell, Anne-Marie Russell, Elissa Murphy, Sebastian L Johnston, David A Schwartz, Athol U Wells,[...]. Am J Respir Crit Care Med 2014
300
5

Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis.
Charlotte Hill, Juanjuan Li, Dian Liu, Franco Conforti, Christopher J Brereton, Liudi Yao, Yilu Zhou, Aiman Alzetani, Serena J Chee, Ben G Marshall,[...]. Cell Death Dis 2019
57
8

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
663
5

PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production.
Lindsay J Celada, Jonathan A Kropski, Jose D Herazo-Maya, Weifeng Luo, Amy Creecy, Andrew T Abad, Ozioma S Chioma, Grace Lee, Natalie E Hassell, Guzel I Shaginurova,[...]. Sci Transl Med 2018
103
5

Scutellarein inhibits BLM-mediated pulmonary fibrosis by affecting fibroblast differentiation, proliferation, and apoptosis.
Kang Miao, Ting Pan, Yong Mou, Lei Zhang, Weining Xiong, Yongjian Xu, Jun Yu, Yi Wang. Ther Adv Chronic Dis 2020
13
38

M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis.
Jiwei Hou, Jingyan Shi, Ling Chen, Zhongyang Lv, Xiang Chen, Honghui Cao, Zou Xiang, Xiaodong Han. Cell Commun Signal 2018
54
9

Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.
Changfu Yao, Xiangrong Guan, Gianni Carraro, Tanyalak Parimon, Xue Liu, Guanling Huang, Apoorva Mulay, Harmik J Soukiasian, Gregory David, Stephen S Weigt,[...]. Am J Respir Crit Care Med 2021
50
10

Standardized quantification of pulmonary fibrosis in histological samples.
Ralf-Harto Hübner, Wolfram Gitter, Nour Eddine El Mokhtari, Micaela Mathiak, Marcus Both, Hendrik Bolte, Sandra Freitag-Wolf, Burkhard Bewig. Biotechniques 2008
285
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.